Glossary »
Stock Information
Price (Prev Close)
|
749.00
|
Price - 52 Week High
|
1,133.00
|
Price - 52 Week Low
|
646.00
|
Price Date (Latest)
|
Apr 26, 2018
|
Median Price Target
|
6,385.79
|
Diff from Prev Close
|
276.50
|
% Difference
|
36.92%
|
Analyst Ratings
1 Strong Buy
|
1
|
2 Buy
|
0
|
3 Hold
|
4
|
4 Underperform
|
2
|
5 Sell
|
0
|
Mean Recommendation: 3.00
Reference Information
Last Actual (FY0)
|
33.59
|
FY0 End Date
|
Dec '16
|
Indicated Annual Div.
|
5.00
|
Hist (5 Yr) Growth %
|
19.75 %
|
Hist (5 Yr) Stability %
|
41.90 %
|
Yield (%)
|
0.51 %
|
Analyst Forecasts
Last Month Revisions
Fiscal Period
|
Mean
|
High
|
Low
|
Median
|
# of Estimates
|
# Up
|
# Down
|
Mean % Change
|
Annual Dec '19 |
27.95 |
35.37 |
20.80 |
27.59 |
5 |
2 |
0 |
2.77 % |
Annual Dec '18 |
17.10 |
23.41 |
6.68 |
22.47 |
5 |
1 |
2 |
0.27 % |
Annual Dec '17 |
2.16 |
11.50 |
-4.85 |
0.61 |
5 |
0 |
3 |
-9.08 % |
Quarterly Sep '17 |
-1.50 |
1.90 |
-4.84 |
-1.54 |
4 |
0 |
2 |
87.54 % |
Quarterly Dec '17 |
2.23 |
5.00 |
-0.08 |
2.00 |
4 |
1 |
1 |
36.66 % |
Long Term Growth N/A |
12.70 |
12.70 |
12.70 |
12.70 |
1 |
0 |
0 |
- |
Actuals
Fiscal Period |
Reported EPS |
Mean Estimates |
Surprise % Change |
Annual Dec '16 |
33.59 |
31.18 |
7.72 % |
Quarterly Sep '16 |
5.00 |
2.80 |
78.57 % |
Quarterly Dec '16 |
6.79 |
3.30 |
105.76 % |
Quarterly Mar '17 |
0.00 |
5.45 |
-100.00 % |
Quarterly Jun '17 |
0.00 |
0.84 |
-100.00 % |
Annual Dec '15 |
35.05 |
23.71 |
47.83 % |
Annual Dec '14 |
22.71 |
23.04 |
-1.43 % |
P/E Ratios
ALK - eafe health care
Fiscal Period
|
ALK
|
eafe health care
|
Industry Relative
|
FY0 |
29.47 |
24.07 |
1.22 |
FY1 |
457.49 |
22.20 |
20.60 |
FY2 |
57.88 |
20.25 |
2.86 |
EPS Growth Rates
ALK - eafe health care
Growth Rates |
ALK |
eafe health care |
Industry Relative |
FY1/FY0 |
-93.56 |
8.55 |
0.06 |
FY2/FY1 |
690.39 |
9.74 |
7.20 |
FY3/FY2 |
63.42 |
9.20 |
1.50 |
Disclaimer: Mean earnings estimates are calculated by First Call based on their earnings projections made by the analysts who cover ALK. Please note that any opinions, estimates or forecasts regarding ALK's performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of ALK or its management. ALK does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
Prices are in DKK